The use of the systems that treat the common femoral artery (CFA) right after the implantation of the stent graft into the abdominal aortic aneurysm constitutes the next important step towards the minimization of the perioperative traumas. The endovascular method of treatment, which was developed by Prodi in the 1990s, became a viable way for the aneurysm treatment in patients with various cardiological ailments. This was possible because of the minimal invasive nature of the endovascular method in comparison to the standard method of treating aneurysms (1) . The Percutaneous Endovascular Aneurysm Repair (PEVAR) became a widely used method and also constituted a desirable supplementation of the whole treatment.
The essential aim of the study was to treat the abdominal aortic aneurysms in an "entirely percutaneous" way with the use of the vascular closure device (system). Additionally, the likelihood of complications occurrence as well as the possibility of intraoperative treatment of such complications was evaluated. The estimated cost of the endovascular treatment with the use of ProStar XL was also calculated. Furthermore, the cost of this treatment was 
MATERIAL AND METHODS
Material for conducting this study was based on a group of 21 patients who were suitable candidates for the endovascular abdominal aortic aneurysm repair within the infrarenal region. The procedure included the implementation of the ProStar XL percutaneous closure device. On the basis of the previously conducted A-KT diagnosis, the group of 21 patients was qualified for the endovascular treatment of the abdominal aortic aneurysm. The type of the stent graft to be used in the procedure was determined from the CT-angiogram imaging and the anatomy of the aneurysm and its surroundings (including the length of the neck, the distance between the aneurysm and the outlet of the "lower" renal artery, the angulation, and the diameter of the iliac arteries). Additionally, in order to determine whether the ProStar XL closure device can be used, each of the patients underwent USG Doppler imaging of the common femoral artery (CFA). Consequently, the presence of the plaque on the anterior wall of the artery would automatically exclude the implementation of the ProStar XL closure device. Figures  1 and 2 show the image of Doppler ultrasound, which was the suitability criterion for the PEVAR treatment.
The operating area (both groins) was prepared in a standard way. Using the percutaneous regional anesthesia, and under the surveillance of the ultrasound image received through the punctuation of the right common femoral artery (RCFA), the introductory device (the pusher rod) with the valve was carefully inserted (artery lock) No.7. In a similar way the introductory device (the pusher rod) was inserted in the left common femoral artery (LCFA). Small incisions into the skin in order to separate the tissue were made. Next, the penetration channel leading to the anterior wall of the artery was created ( fig. 3 ). The removal of the previously introduced pusher rod was possible through the implementation of the guide wire and, this way, the ProStar XL closure device could be set up. In this very moment of the procedure the attention to the necessity of thorough preparation must be paid. It is important that the focus should be put on ruling out the slightest possibility of the soft tissue interposition, which would inevitably prevent the correct placement of sutures. It is also important to let the suture strands out to the surface of the skin, check the smoothness of their movement, and their fixation. This is to make sure that the strands would not tangle and knot. This constitutes the first step of the procedure.
The next step of the procedure, basing on the previously conducted A-KT imaging for the purpose of choosing the appropriate type of stent graft, poses the implantation of the main body of the stent graft as well as its contralateral side and the ipsi-lateral limb. Arteriography confirmed the correct implantation of the endograft as well as its tightness. The sutures that were placed using the ProStar XL closure system in the first step of the procedure were tightened during the second step of the procedure and according to the appropriate code of practice. Figure 4 shows the final visual effect of the procedure.
According to the standard practice, 5 thousand units of the unfractionated heparin and 1 g of Cefazolin (first-generation cephalosporin antibiotic) were administered to each patient. During the first 24 hours after the procedure each patient was subjected to USG Doppler of the CFA (bilaterally) with the purpose of diagnosing possible hematoma or pseudo aneurysm. Table 1 shows the treatment process, complications, and hospitalization period in each case. -4  2  M  72  TAB  bifurcated  --3  3  M  81  TAB  bifurcated  --3  4  M  67  TAB  bifurcated  --3  5  F  59  TAB  bifurcated  --3  6  M  64  TAB  bifurcated  --3  7  M  77  TAB  bifurcated  --2  8  F  79  TAB  bifurcated  --3  9  F  71  TAB  bifurcated  --3  10  M  74  TAB  bifurcated  --3  11  M  72  TAB  bifurcated  --4  12  M  83  TAB  bifurcated  --3  13  M  73  TAB  bifurcated  bleeding  open surgery  5  14  M  64  TAB  bifurcated  -2  15  M  54  TAB  bifurcated  -2  16  F  70  TAB  bifurcated  -3  17  M  59  TAB  bifurcated  -2  18  M  69  TAB  bifurcated  -3  19  F  71  TAB  bifurcated  -2  20  M  48  TAB  bifurcated  -2  21  F  81  TAB  bifurcated  -4 Among the 21 patients there was only one case with a complication. The bleeding started from the exact area where the ProStar XL system was introduced and continued to the lumen of the CFA. In result, during the intraoperative period operating surgeons switched back to the standard method. The artery had to be uncovered and the previously made incision was made wider. The gap in the CFA anterior wall was treated with the continuous period within the group of patients who were not treated with the ProStar XL The control group included 17 males (88.95%) in the age of 65-84 and 4 females (19.04%) in the age of 59-79. The average hospitalization period for the whole group indicated 5.19% for females, and 5.23% for males; 5 days on average. Table 3 shows the comparison between the group of observed patients and the control group.
The analysis of these results indicated that the hospitalization period for males and females in the observed group (PEVAR group) was the same and equaled 3 days. The difference between males and females in the control group in terms of hospitalization period was not significant either and equaled 0.23 days. stitch (Prolene 5-0). The patient received 2 units of the PRBC. During the fifth day after the procedure the patient's overall condition was good and the decision about the discharge from the hospital was made.
All subjected to the observation male patients constituted 71.42% (aged 48-83) of the whole group, average age indicated 68.86. Female patients constituted 28.57% (aged 59-81), average age indicated 71,84. The average hospitalization period within the group of 21 patients indicated 2.95 days, males similarly to females -3 days. The obtained results were then compared with the group of 21 patients subjected to the EVAR but without the use of the ProStar XL. Table 2 shows the process and results of the treatment, complications and hospitalization --5  7  M  71  TAB  bifurcated  --5  8  F  59  TAB  bifurcated  --4  9  M  78  TAB  bifurcated  hematoma  eavacuation  7  10  M  74  TAB  bifurcated  --5  11  M  76  TAB  bifurcated  --5  12  M  77  TAB  bifurcated  --6  13  M  78  TAB  bifurcated  --5  14  M  81  TAB  bifurcated  --6  15  M  83  TAB  bifurcated  --5  16  M  76  TAB  bifurcated  --5  17  M  65  TAB  bifurcated  --4  18  M  66  TAB  bifurcated  --4  19  F  79  TAB  bifurcated  --6  20  M  80  TAB  bifurcated  lymphorrhoea cauterisation  8  21  F  67  TAB  bifurcated  --5 However, the comparison of the two groups (observed PEVAR and control groups) showed a significant difference in the overall hospitalization period. This difference equaled 2.24 days and constituted 56.84%. The obtained results are no different from the results presented in the world medical literature (3).
DISCUSSION
The Percutaneous Vascular Closure Systems (ProStarXL) have become valuable supplementations for various endovascular procedures, including the intravascular treatment of the abdominal aortic aneurysms. The deployment of these closure systems significantly decreased the invasive nature of vascular procedures (2) . Another measurable benefit of such closure systems is the significantly shortened period for hospitalization, which was proven by the observations conducted in this study. Additionally, these closure systems reduce the overall costs (at clinical vascular departments) of such vascular treatments and this fact provides a crucial advantage in terms of the present economic situation in the healthcare sector (4) .
The results presented in this study include the use of the closure system ProStar XL (in EVAR procedure) and were based on the group of 21 patients, and constitute an in-house, own experience of the authors or this article. It is important to state that all of the 21 patients underwent the bilateral closure of the common femoral artery (CFA) after the endovascular abdominal aortic aneurysm repair within the infrarenal region. After analyzing the complication that occurred in one of the patients it is important to add that this sort of complication resulted from insufficient experience involving the process of tightening the sutures, and lead to their rupture. The lack of possibility to place a hemoclip onto the unprepared artery (PE-VAR method) only highlights the gravity of the situation. The solution, however, was found in the stent graft's transport-deploy system which was reintroduced with the use of the guide wire already present in the lumen of the CFA. In this way, the bleeding was successfully stopped. Next, the artery was uncovered, clamped and the continuous stitch (Prolene 5-0) placed right onto the gap in the artery's anterior wall. The solution implemented by the authors of this article is also recommended by Canadian authors S. Marlene Grenon and co-workers. The article can be found in the Canadian Journal of Surgery (2009) (4). Among other mistakes, which might occur during the procedure implementing the closure system and may lead to the damage to CFA, are: excessive force while introducing the system into the lumen of the artery (crossing the line of the working zone), failure to remove the guidewire that was used to introduce the system, incorrect angulation of the whole system while placing sutures. Figures 5, 6 and 7 show the above described mistakes.
According to the resources from medical literature, it is important to point out the objectionable suitability of patients for PEVAR procedures. Unsuccessful implementation of the "Perclose devise" (5) may be caused by the extensive scarring areas in the groin region, a high-reaching division of the CFA, plaques that are present on the anterior wall of the artery, and critical stenosis of the iliac artery 
